Medicilon Logo
|
search icon search icon language icon contact icon menu icon
Medicilon Logo
|
search icon close search icon language icon contact icon menu icon
logo icon CN
Contact Us
Close Button
Message
Back To Top
Online Message×
Click switch
Close Button
Medicilon's News information
News information

Repeated Dose Toxicity Study

2017-07-13
|
Page View:

Repeated toxicity test (long-term toxicity test) is the new drug to complete the main pharmacodynamics and acute toxicity test to confirm the further study value of the repeated administration of toxicity test to observe the toxic effects of drugs on animals.

Long-term toxicity test is in a period of time (the length of time to take the drug according to the clinical application of the decision, generally over 1 month) by repeated multiple administration, observation of experimental animals, toxic reactions, hematology, blood Biochemical and pathological changes, analysis of the relationship between the dose of toxic effects, the main target organ, the nature and extent of toxic reactions, the reversibility of toxic reactions, animal tolerance, non-toxic reaction dose, toxic reaction dose and safety range; It can also understand the time of toxicity, peak time, duration; whether there is a delayed toxicity, whether there is accumulation of toxicity, tolerance and so on.

Repeated toxicity test is one of the main contents of drug safety evaluation and main basis for the transition to clinical trial. It is important to prescribe the starting dose and safe dose range of the clinical trial, suggesting that the clinical trial focus on monitoring indicators, clinical trial drug poisoning detoxification is of great significance.

Repeated administration toxicity test is the core of non-clinical safety evaluation of drugs; it is acute toxicity, reproductive toxicity and carcinogenicity and other toxicology research, closely linked to the drug from the pharmaceutical research into clinical trials as an important part.
In the course of drug development, the purpose of the long-term toxicity test is to characterize the toxic effects of the test substance by repeated administration of the animal test, to predict the possible adverse effects on the human body and reduce the risk of medication after the use of the clinical trial of subjects.

This test includes the following five aspects:

1. Predicting the possible adverse effects of the test substance, including the nature of adverse reactions, the degree of dose-response relationship and time-response relationship, reversibility, etc.
2. Determine the repeated administration of the test substance Toxic target organ or target tissue
3. Presumptive clinical trial of the initial dose and repeated drug dose range
4. Prompted clinical trials need to focus on monitoring indicators
5, Can also be clinical trials of detoxification or rescue measures to provide a reference.
It must be emphasized that the ultimate goal of repeated administration toxicity tests is to serve clinical trials and clinical medication. The purpose of this principle is to provide a technical reference for long-term toxicity testing and to provide assistance in the technical review of pharmaceuticals and to promote a broader consensus on long-term toxicity testing between drug review agencies and drug registration applicants.

This is a general principle of the long-term toxicity test of chemical drugs, only representing the current basic understanding of long-term toxicity testing, which is not entirely the content of long-term toxicity test that must be completed. The long-term toxicity test of specific drugs should be based on this principle, according to the characteristics of the drug to develop test programs.

Share:
Return
Relevant newsRelevant news